1 High-Flying Stock for Long-Term Investors and 2 That Underwhelm [Yahoo! Finance]
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly. Separating true intrinsic value from speculation isn't easy, especially during bull markets. That's where StockStory comes in - to help you find high-quality companies that will stand the test of time. That said, here is one high-flying stock to hold for the long term and two with big downside risk. Forward P/E Ratio: 34.2x Founded in 1983 and named after a pioneering vascular surgeon, LeMaitre Vascular (NASDAQGM:LMAT) develops and manufactures specialized medical devices used by vascular surgeons to treat peripheral vascular disease and other circulatory conditions. Why Does LMAT Fall Short? Smaller revenue base of $240.9 million means it hasn't achieved the economies of scale that some industry juggernauts enjoy LeMaitre's stock price of $85.79 implies a valuation ratio of 34.2x forward P/E. If you're considering LMAT for your
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial ResultsPR Newswire
- Bio-Techne: Recovery Likely Coming, But Is There Enough Re-Rating Potential? [Seeking Alpha]Seeking Alpha
- Bio-Techne (NASDAQ:TECH) was downgraded by analysts at Evercore ISI from a "strong-buy" rating to a "hold" rating.MarketBeat
- Bio-Techne (NASDAQ:TECH) was given a new $62.00 price target on by analysts at Evercore ISI.MarketBeat
- 1 S&P 500 Stock with Exciting Potential and 2 We Question [Yahoo! Finance]Yahoo! Finance
TECH
Earnings
- 11/5/25 - Beat
TECH
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/5/25 - Form 4
- 11/5/25 - Form 4
- TECH's page on the SEC website